Results 31 to 40 of about 411,697 (349)

Associação entre lúpus eritematoso e tabagismo Association between lupus erythematosus and smoking

Anais Brasileiros de Dermatologia, 2008
FUNDAMENTOS: O lúpus eritematoso é doença crônica, auto-imune, que reúne manifestações exclusivamente cutâneas ou multissistêmicas, caracterizada pela produção de auto-anticorpos contra vários constituintes celulares.
Júnia Maria Fernandes Araújo, Ana Rosa Magaldi Ribeiro de Oliveira, Sâmya Diégues Cedrim, Olímpia Castelo Tristão, Aloísio Gamonal   +4 more
doaj   +1 more source

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects [PDF]

Anais Brasileiros de Dermatologia, 2014
Systemic Lupus Erythematosus is a chronic inflammatory disease with multifactorial etiology. Although clinical manifestations are varied, the skin is an important target-organ, which contributes to the inclusion of skin lesions in 4 out of the 17 new ...
Jucelio Pereira Moura Filho, Raiza Luna Peixoto, Livia Gomes Martins, Sillas Duarte de Melo, Ligiana Leite de Carvalho, Ana Karine F. da Trindade C. Pereira, Eutilia Andrade Medeiros Freire   +6 more
doaj   +1 more source

Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort

Clinics, 2011
OBJECTIVE: The goal of the present study was to estimate the risk ratio of herpes zoster among systemic lupus erythematosus patients after disease onset compared with a cohort of patients without systemic lupus erythematosus over a three-year period ...
Hsin-Hua Chen, Yi-Ming Chen, Tzeng-Ji Chen, Joung-Liang Lan, Ching-Heng Lin, Der-Yuan Chen   +5 more
doaj   +1 more source

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE

Lupus Science and Medicine, 2023
Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific mucocutaneous manifestations in patients with systemic lupus ...
Jun Kang, Aaron Bao
doaj   +1 more source

Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project

Arthritis care & research, 2020
The California Lupus Surveillance Project (CLSP) is a population‐based registry of individuals with systemic lupus erythematosus (SLE) residing in San Francisco County, California from 2007 to 2009, with a special focus on Asian/Pacific Islander and ...
Ernest Maningding, M. Dall'era, L. Trupin, L. Murphy, J. Yazdany   +4 more
semanticscholar   +1 more source

Trial of Anifrolumab in Active Systemic Lupus Erythematosus.

New England Journal of Medicine, 2019
BACKGROUND Anifrolumab, a human monoclonal antibody to type I interferon receptor subunit 1 investigated for the treatment of systemic lupus erythematosus (SLE), did not have a significant effect on the primary end point in a previous phase 3 trial.
E. Morand, R. Furie, Yoshiya Tanaka, I. Bruce, A. Askanase, C. Richez, S. Bae, P. Brohawn, L. Pineda, A. Berglind, R. Tummala   +10 more
semanticscholar   +1 more source

Developing classification criteria for discoid lupus erythematosus: an update from the World Congress of Dermatology 2015 meeting

International Journal of Women's Dermatology, 2016
Currently, no standardized classification criteria exist for cutaneous lupus erythematosus. With increased interest in studying cutaneous lupus erythematosus, specifically discoid lupus erythematosus, it is our aim to apply previously adopted methods ...
Scott A. Elman, AB, Filippa Nyberg, MD, Fukumi Furukawa, MD, Mark Goodfield, MD, Minoru Hasegawa, MD, Branka Marinovic, MD, Jacek Szepietowski, MD, Jan Dutz, MD, FRCPC, Victoria P. Werth, MD, Joseph F. Merola, MD, MMSc   +9 more
doaj   +1 more source

Cutaneous lupus erythematosus: pathogenesis, clinical pattern, diagnostics, therapy

Vestnik Dermatologii i Venerologii, 2017
This article contains the latest information about the mechanisms of development of lupus erythematosus based on the literature review. The modern classification of specific and non-specific skin lesions in lupus erythematosus is shown.The authors ...
P. N. Trofimov, O. V. Antonova, D. N. Shvyrev, V. R. Khairutdinov, I. E. Belousova, A. V. Samtsov   +5 more
doaj   +1 more source

LUPUS ERYTHEMATOSUS [PDF]

British Journal of Dermatology, 1892
n ...
openaire   +1 more source

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin, Gregory Sahagian, Marc H. Feinberg, C. Andrew Stewart, Christopher M. Jewell, Metin Kurtoglu, Miloš D. Miljković, Tuan Vu, Tahseen Mozaffar, James F. Howard Jr, the MG‐001 Study Group   +10 more
wiley   +1 more source